Literature DB >> 24784380

Evaluation of dual energy quantitative CT for determining the spatial distributions of red marrow and bone for dosimetry in internal emitter radiation therapy.

Mitchell M Goodsitt1, Apeksha Shenoy1, Jincheng Shen2, David Howard1, Matthew J Schipper3, Scott Wilderman4, Emmanuel Christodoulou1, Se Young Chun5, Yuni K Dewaraja1.   

Abstract

PURPOSE: To evaluate a three-equation three-unknown dual-energy quantitative CT (DEQCT) technique for determining region specific variations in bone spongiosa composition for improved red marrow dose estimation in radionuclide therapy.
METHODS: The DEQCT method was applied to 80/140 kVp images of patient-simulating lumbar sectional body phantoms of three sizes (small, medium, and large). External calibration rods of bone, red marrow, and fat-simulating materials were placed beneath the body phantoms. Similar internal calibration inserts were placed at vertebral locations within the body phantoms. Six test inserts of known volume fractions of bone, fat, and red marrow were also scanned. External-to-internal calibration correction factors were derived. The effects of body phantom size, radiation dose, spongiosa region segmentation granularity [single (∼17 × 17 mm) region of interest (ROI), 2 × 2, and 3 × 3 segmentation of that single ROI], and calibration method on the accuracy of the calculated volume fractions of red marrow (cellularity) and trabecular bone were evaluated.
RESULTS: For standard low dose DEQCT x-ray technique factors and the internal calibration method, the RMS errors of the estimated volume fractions of red marrow of the test inserts were 1.2-1.3 times greater in the medium body than in the small body phantom and 1.3-1.5 times greater in the large body than in the small body phantom. RMS errors of the calculated volume fractions of red marrow within 2 × 2 segmented subregions of the ROIs were 1.6-1.9 times greater than for no segmentation, and RMS errors for 3 × 3 segmented subregions were 2.3-2.7 times greater than those for no segmentation. Increasing the dose by a factor of 2 reduced the RMS errors of all constituent volume fractions by an average factor of 1.40 ± 0.29 for all segmentation schemes and body phantom sizes; increasing the dose by a factor of 4 reduced those RMS errors by an average factor of 1.71 ± 0.25. Results for external calibrations exhibited much larger RMS errors than size matched internal calibration. Use of an average body size external-to-internal calibration correction factor reduced the errors to closer to those for internal calibration. RMS errors of less than 30% or about 0.01 for the bone and 0.1 for the red marrow volume fractions would likely be satisfactory for human studies. Such accuracies were achieved for 3 × 3 segmentation of 5 mm slice images for: (a) internal calibration with 4 times dose for all size body phantoms, (b) internal calibration with 2 times dose for the small and medium size body phantoms, and (c) corrected external calibration with 4 times dose and all size body phantoms.
CONCLUSIONS: Phantom studies are promising and demonstrate the potential to use dual energy quantitative CT to estimate the spatial distributions of red marrow and bone within the vertebral spongiosa.

Entities:  

Mesh:

Year:  2014        PMID: 24784380      PMCID: PMC4000400          DOI: 10.1118/1.4870378

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  21 in total

1.  In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy.

Authors:  D Ballon; A Jakubowski; J Gabrilove; M C Graham; M Zakowski; C Sheridan; J A Koutcher
Journal:  Magn Reson Med       Date:  1991-05       Impact factor: 4.668

2.  Accuracy of vertebral mineral determination by dual-energy quantitative computed tomography.

Authors:  W D Reinbold; C P Adler; W A Kalender; R Lente
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

3.  Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow.

Authors:  H Kugel; C Jung; O Schulte; W Heindel
Journal:  J Magn Reson Imaging       Date:  2001-02       Impact factor: 4.813

4.  Two postprocessing CT techniques for determining the composition of trabecular bone.

Authors:  M M Goodsitt; D I Rosenthal; W R Reinus; J Coumas
Journal:  Invest Radiol       Date:  1987-03       Impact factor: 6.016

5.  Bone marrow cellularity: quantification by chemical-shift misregistration in magnetic resonance imaging and comparison with histomorphometrical techniques.

Authors:  H Ishizaka; H Horikoshi; T Inoue; T Fukusato; M Matsumoto
Journal:  Australas Radiol       Date:  1995-11

6.  The composition of bone marrow for a dual-energy quantitative computed tomography technique. A cadaver and computer simulation study.

Authors:  M M Goodsitt; P Hoover; M S Veldee; S L Hsueh
Journal:  Invest Radiol       Date:  1994-07       Impact factor: 6.016

7.  The composition of body tissues.

Authors:  H Q Woodard; D R White
Journal:  Br J Radiol       Date:  1986-12       Impact factor: 3.039

8.  A new set of calibration standards for estimating the fat and mineral content of vertebrae via dual energy QCT.

Authors:  M M Goodsitt; R H Johnson; C H Chesnut
Journal:  Bone Miner       Date:  1991-06

9.  Spinal bone mineral density measured with quantitative CT: effect of region of interest, vertebral level, and technique.

Authors:  P Steiger; J E Block; S Steiger; A F Heuck; A Friedlander; B Ettinger; S T Harris; C C Glüer; H K Genant
Journal:  Radiology       Date:  1990-05       Impact factor: 11.105

10.  Investigation of effect of variations in bone fraction and red marrow cellularity on bone marrow dosimetry in radio-immunotherapy.

Authors:  S J Wilderman; P L Roberson; W E Bolch; Y K Dewaraja
Journal:  Phys Med Biol       Date:  2013-06-19       Impact factor: 3.609

View more
  1 in total

1.  Spectral CT of the Extremities with a Silicon Strip Photon Counting Detector.

Authors:  A Sisniega; W Zbijewski; J W Stayman; J Xu; K Taguchi; J H Siewerdsen
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.